{
  "id": 8016379,
  "title": "H.C. Wainwright reiterates Buy on Connect Biopharma stock at $7",
  "url": "https://urgent.news/2026/09/17/h-c-wainwright-reiterates-buy-on-connect-biopharma-stock-at-7",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-17T11:44:47.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-on-connect-biopharma-stock-at-7-93CH-4905437"
  },
  "original_language": "en",
  "account": "H.C. Wainwright has reaffirmed its Buy rating and set a price target of $7.00 for Connect Biopharma Holdings Ltd (NASDAQ:CNTB) after reviewing the results of the company's Phase 2 Seabreeze STAT asthma trial. The trial did not meet statistical significance for the treatment-failure primary endpoint, but the drug rademikibart still demonstrated a rapid, statistically significant, and clinically meaningful improvement in lung function. However, the study fell short of having a clean dataset, which may have left investors with a lower expectation. Despite this, H.C. Wainwright believes the Seabreeze trial does not raise any significant concerns about rademikibart's efficacy or safety. The company's rademikibart is currently valued at $78.1 million with a price target ranging from $4 to $10 according to InvestingPro analysis. Connect Biopharma is also expected to release COPD data later this month and is awaiting FDA agreement on an acute-asthma endpoint, which H.C. Wainwright considers a potential catalyst. Other analysts, such as Canaccord and Oppenheimer, have also maintained their Buy or Outperform ratings with price targets between $6 and $8 for Connect Biopharma.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Stifel reiterates Generac stock Buy rating on $8B Amazon deal",
        "url": "https://urgent.news/2026/09/17/stifel-reiterates-generac-stock-buy-rating-on-8b-amazon-deal",
        "published": "2026-09-17T11:52:43.000Z"
      },
      {
        "outlet": "Yahoo Finance",
        "title": "Amazon Deal Sends Generac Stock Skyrocketing",
        "url": "https://urgent.news/2026/09/17/amazon-deal-sends-generac-stock-skyrocketing",
        "published": "2026-09-17T11:58:54.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}